Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
304.60    8.30 (2.80%)
Bid:
303.70
Ask:
303.90
Spread: 0.20 (0.066%)
Market Cap: £6.75b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

Directorate Changes

12 Mar 2021 09:00

RNS Number : 9998R
Sainsbury(J) PLC
12 March 2021
 

12 March 2021

J Sainsbury plc - Directorate Changes

Appointment of Adrian Hennah as Non-Executive Director and Chair of Audit Committee

J Sainsbury plc today announces that Adrian Hennah will join the Board as a Non-Executive Director. Adrian will join the Audit Committee and Nomination Committee on 1 April 2021 and will take over as Chair of the Audit Committee following the AGM.

Adrian will replace David Keens, who is not seeking re-election to the Board at the July 2021 AGM after six years of service.

Commenting on the appointment, Martin Scicluna, Chairman of Sainsbury's, said:

"I am delighted to welcome Adrian as a Non-Executive Director and Chair of the Audit Committee. As a highly accomplished CFO of three FTSE100 companies spanning 18 years, he has significant and varied expertise. Additionally, Adrian was a Non-Executive Director and Audit Committee Chair of another FTSE100 company for nine years and I am confident he will bring fresh thinking to our Board as we deliver against our plan.

"I would like to thank David Keens for his six years of service. He has been a thoughtful and influential voice on the Board and we are grateful for his significant contribution."

Adrian Hennah said:

"I am very pleased to be joining Sainsbury's and look forward to bringing my experience to the Board. I am familiar with the business through previous roles and have always been impressed by the company's values and commitment to do the right thing for its customers. It is an exciting time to be involved in food retail and I am looking forward to getting started."

Adrian spent 18 years in Chief Financial Officer (CFO) roles at three FTSE 100 companies. He was CFO at RB for seven years and held the same position at Smith & Nephew and Invensys. Prior to this he spent 18 years at GSK working in both finance and operations. Adrian began his career at PWC.

Adrian was previously Non-Executive Director and Chair of the Audit Committee at RELX. He stepped down from the Board last year having completed nine years of service. No further information is required to be disclosed under 9.6.13R of the UK Listing Rules.

 

Ends

Enquiries:

Investor Relations Media Relations

James Collins +44 (0) 20 7695 0080 Rebecca Reilly +44 (0) 20 7695 7295

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZFLFFFXLEBBF
Date   Source Headline
17th Feb 20232:15 pmRNSDirector/PDMR Shareholding
7th Feb 20239:00 amRNSDirector/PDMR Shareholding
1st Feb 20233:30 pmRNSBlock listing Interim Review
1st Feb 20231:35 pmRNSTotal Voting Rights
1st Feb 20238:15 amRNSHolding(s) in Company
30th Jan 202312:00 pmRNSDirector/PDMR Shareholding
27th Jan 20237:03 amRNSResponse to Bestway Group Announcement
27th Jan 20237:00 amRNSAcquisition of shares in J Sainsbury plc
20th Jan 20233:50 pmRNSDirector/PDMR Shareholding
13th Jan 20232:00 pmRNSDirector/PDMR Shareholding
11th Jan 20239:36 amRNSQ3 Trading Statement - Replacement
11th Jan 20237:00 amRNSQ3 Trading Statement
3rd Jan 20231:35 pmRNSTotal Voting Rights
23rd Dec 202212:15 pmRNSDirector/PDMR Shareholding
12th Dec 20229:15 amRNSDirector/PDMR Shareholding
1st Dec 202211:35 amRNSTotal Voting Rights
25th Nov 202212:30 pmRNSDirector/PDMR Shareholding
10th Nov 202211:00 amRNSDirector/PDMR Shareholding
9th Nov 20224:00 pmRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNSHalf-year Report
1st Nov 20223:00 pmRNSTotal Voting Rights
28th Oct 20224:03 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:30 pmRNSTotal Voting Rights
30th Sep 20223:20 pmRNSDirector/PDMR Shareholding
26th Sep 20227:06 amRNSProperty Transaction Update
21st Sep 202210:01 amRNSProperty Transactions
7th Sep 20224:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20221:05 pmRNSDirector/PDMR Shareholding
1st Sep 202212:45 pmRNSTotal Voting Rights
5th Aug 20223:45 pmRNSDirector/PDMR Shareholding
1st Aug 20224:31 pmRNSBlock listing Interim Review
1st Aug 20222:45 pmRNSTotal Voting Rights
21st Jul 20229:00 amRNSAdditional Listing
8th Jul 20224:20 pmRNSDirector/PDMR Shareholding
7th Jul 20222:30 pmRNSResults of AGM
5th Jul 20227:00 amRNSDirectorate Change
5th Jul 20227:00 amRNSTrading Statement
1st Jul 20221:45 pmRNSTotal Voting Rights
10th Jun 20225:20 pmRNSDirector/PDMR Shareholding
6th Jun 20223:00 pmRNSDirector/PDMR Shareholding
6th Jun 20221:15 pmRNSAnnual Report and Notice of AGM 2022
1st Jun 202211:45 amRNSTotal Voting Rights
13th May 20222:30 pmRNSDirector/PDMR Shareholding
12th May 20224:30 pmRNSDirector/PDMR Shareholding
3rd May 20225:20 pmRNSTotal Voting Rights
28th Apr 20227:00 amRNSFinal Results
19th Apr 20222:15 pmRNSDirector/PDMR Shareholding
14th Apr 20227:00 amRNSDirectorate Changes
1st Apr 20221:15 pmRNSTotal Voting Rights
18th Mar 20222:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.